ID   FGD1_HUMAN              Reviewed;         961 AA.
AC   P98174; Q5H999; Q8N4D9;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2003, sequence version 2.
DT   28-JUN-2023, entry version 205.
DE   RecName: Full=FYVE, RhoGEF and PH domain-containing protein 1;
DE   AltName: Full=Faciogenital dysplasia 1 protein;
DE   AltName: Full=Rho/Rac guanine nucleotide exchange factor FGD1;
DE            Short=Rho/Rac GEF;
DE   AltName: Full=Zinc finger FYVE domain-containing protein 3;
GN   Name=FGD1; Synonyms=FGDY, ZFYVE3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Craniofacial;
RX   PubMed=7954831; DOI=10.1016/0092-8674(94)90552-5;
RA   Pasteris N.G., Cadle A., Logie L.J., Porteous M.E.M., Schwartz C.E.,
RA   Stevenson R.E., Glover T.W., Wilroy R.S., Gorski J.L.;
RT   "Isolation and characterization of the faciogenital dysplasia (Aarskog-
RT   Scott syndrome) gene: a putative Rho/Rac guanine nucleotide exchange
RT   factor.";
RL   Cell 79:669-678(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=8969170; DOI=10.1074/jbc.271.52.33169;
RA   Zheng Y., Fischer D.J., Santos M.F., Tigyi G., Pasteris N.G., Gorski J.L.,
RA   Xu Y.;
RT   "The faciogenital dysplasia gene product FGD1 functions as a Cdc42Hs-
RT   specific guanine-nucleotide exchange factor.";
RL   J. Biol. Chem. 271:33169-33172(1996).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; SER-205; THR-711 AND
RP   SER-715, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   VARIANT AAS HIS-522.
RX   PubMed=11093277; DOI=10.1038/sj.ejhg.5200553;
RA   Schwartz C.E., Gillessen-Kaesbach G., May M., Cappa M., Gorski J.L.,
RA   Steindl K., Neri G.;
RT   "Two novel mutations confirm FGD1 is responsible for the Aarskog
RT   syndrome.";
RL   Eur. J. Hum. Genet. 8:869-874(2000).
RN   [10]
RP   VARIANT AAS GLN-610.
RX   PubMed=10930571; DOI=10.1016/s0014-5793(00)01857-3;
RA   Orrico A., Galli L., Falciani M., Bracci M., Cavaliere M.L., Rinaldi M.M.,
RA   Musacchio A., Sorrentino V.;
RT   "A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an
RT   Italian family with faciogenital dysplasia (Aarskog-Scott syndrome).";
RL   FEBS Lett. 478:216-220(2000).
RN   [11]
RP   VARIANT LEU-312.
RX   PubMed=11940089; DOI=10.1034/j.1399-0004.2002.610209.x;
RA   Lebel R.R., May M., Pouls S., Lubs H.A., Stevenson R.E., Schwartz C.E.;
RT   "Non-syndromic X-linked mental retardation associated with a missense
RT   mutation (P312L) in the FGD1 gene.";
RL   Clin. Genet. 61:139-145(2002).
RN   [12]
RP   VARIANTS AAS ILE-205; ALA-380 AND HIS-443.
RX   PubMed=14560308; DOI=10.1038/sj.ejhg.5201081;
RA   Orrico A., Galli L., Cavaliere M.L., Garavelli L., Fryns J.-P.,
RA   Crushell E., Rinaldi M.M., Medeira A., Sorrentino V.;
RT   "Phenotypic and molecular characterisation of the Aarskog-Scott syndrome: a
RT   survey of the clinical variability in light of FGD1 mutation analysis in 46
RT   patients.";
RL   Eur. J. Hum. Genet. 12:16-23(2004).
CC   -!- FUNCTION: Activates CDC42, a member of the Ras-like family of Rho- and
CC       Rac proteins, by exchanging bound GDP for free GTP. Plays a role in
CC       regulating the actin cytoskeleton and cell shape.
CC       {ECO:0000269|PubMed:8969170}.
CC   -!- SUBUNIT: Interacts with DBNL/ABP1 and CTTN. May interact with CCPG1 (By
CC       similarity). Binds CDC42. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell projection,
CC       lamellipodium {ECO:0000250}. Cell projection, ruffle {ECO:0000250}.
CC       Cytoplasm, cytoskeleton {ECO:0000250}. Note=Associated with membrane
CC       ruffles and lamellipodia. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in fetal heart, brain, lung, kidney and
CC       placenta. Less expressed in liver; adult heart, brain, lung, pancreas
CC       and skeletal muscle.
CC   -!- DOMAIN: The DH domain is involved in interaction with CCPG1.
CC       {ECO:0000250}.
CC   -!- DISEASE: Aarskog-Scott syndrome (AAS) [MIM:305400]: An X-linked
CC       recessive, rare multisystemic disorder characterized by
CC       disproportionately short stature, and by facial, skeletal and
CC       urogenital anomalies. Some patients manifest intellectual disability,
CC       attention deficit disorder and hyperactivity.
CC       {ECO:0000269|PubMed:10930571, ECO:0000269|PubMed:11093277,
CC       ECO:0000269|PubMed:14560308}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U11690; AAA57004.1; -; mRNA.
DR   EMBL; Z85987; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471154; EAW93179.1; -; Genomic_DNA.
DR   EMBL; BC034530; AAH34530.1; -; mRNA.
DR   CCDS; CCDS14359.1; -.
DR   PIR; A55380; A55380.
DR   RefSeq; NP_004454.2; NM_004463.2.
DR   AlphaFoldDB; P98174; -.
DR   SMR; P98174; -.
DR   BioGRID; 108536; 42.
DR   ELM; P98174; -.
DR   IntAct; P98174; 23.
DR   STRING; 9606.ENSP00000364277; -.
DR   BindingDB; P98174; -.
DR   ChEMBL; CHEMBL2862; -.
DR   iPTMnet; P98174; -.
DR   PhosphoSitePlus; P98174; -.
DR   BioMuta; FGD1; -.
DR   DMDM; 28202247; -.
DR   EPD; P98174; -.
DR   jPOST; P98174; -.
DR   MassIVE; P98174; -.
DR   MaxQB; P98174; -.
DR   PaxDb; P98174; -.
DR   PeptideAtlas; P98174; -.
DR   ProteomicsDB; 57809; -.
DR   Antibodypedia; 376; 81 antibodies from 21 providers.
DR   DNASU; 2245; -.
DR   Ensembl; ENST00000375135.4; ENSP00000364277.3; ENSG00000102302.8.
DR   GeneID; 2245; -.
DR   KEGG; hsa:2245; -.
DR   MANE-Select; ENST00000375135.4; ENSP00000364277.3; NM_004463.3; NP_004454.2.
DR   UCSC; uc004dtg.3; human.
DR   AGR; HGNC:3663; -.
DR   CTD; 2245; -.
DR   DisGeNET; 2245; -.
DR   GeneCards; FGD1; -.
DR   HGNC; HGNC:3663; FGD1.
DR   HPA; ENSG00000102302; Low tissue specificity.
DR   MalaCards; FGD1; -.
DR   MIM; 300546; gene.
DR   MIM; 305400; phenotype.
DR   neXtProt; NX_P98174; -.
DR   OpenTargets; ENSG00000102302; -.
DR   Orphanet; 915; Aarskog-Scott syndrome.
DR   PharmGKB; PA28102; -.
DR   VEuPathDB; HostDB:ENSG00000102302; -.
DR   eggNOG; KOG4424; Eukaryota.
DR   GeneTree; ENSGT00940000159438; -.
DR   HOGENOM; CLU_011755_1_1_1; -.
DR   InParanoid; P98174; -.
DR   OMA; QQRWMAV; -.
DR   OrthoDB; 5385125at2759; -.
DR   PhylomeDB; P98174; -.
DR   TreeFam; TF316247; -.
DR   PathwayCommons; P98174; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   SignaLink; P98174; -.
DR   SIGNOR; P98174; -.
DR   BioGRID-ORCS; 2245; 14 hits in 774 CRISPR screens.
DR   ChiTaRS; FGD1; human.
DR   GeneWiki; FGD1; -.
DR   GenomeRNAi; 2245; -.
DR   Pharos; P98174; Tbio.
DR   PRO; PR:P98174; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P98174; protein.
DR   Bgee; ENSG00000102302; Expressed in cortical plate and 118 other tissues.
DR   ExpressionAtlas; P98174; baseline and differential.
DR   Genevisible; P98174; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0001726; C:ruffle; ISS:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031267; F:small GTPase binding; IDA:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0007010; P:cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0046847; P:filopodium assembly; IDA:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; ISS:UniProtKB.
DR   GO; GO:0043087; P:regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd15741; FYVE_FGD1_2_4; 1.
DR   CDD; cd01219; PH1_FGD1; 1.
DR   CDD; cd13236; PH2_FGD1-4; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; Dbl homology (DH) domain; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR035941; FGD1-4_PH2.
DR   InterPro; IPR035939; FGD1_PH1.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000306; Znf_FYVE.
DR   InterPro; IPR017455; Znf_FYVE-rel.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR12673; FACIOGENITAL DYSPLASIA PROTEIN; 1.
DR   PANTHER; PTHR12673:SF79; FYVE, RHOGEF AND PH DOMAIN-CONTAINING PROTEIN 1; 1.
DR   Pfam; PF01363; FYVE; 1.
DR   Pfam; PF00169; PH; 2.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00064; FYVE; 1.
DR   SMART; SM00233; PH; 2.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; DBL homology domain (DH-domain); 1.
DR   SUPFAM; SSF50729; PH domain-like; 2.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 2.
DR   PROSITE; PS50178; ZF_FYVE; 1.
PE   1: Evidence at protein level;
KW   Cell projection; Cytoplasm; Cytoskeleton; Disease variant;
KW   Guanine-nucleotide releasing factor; Metal-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Zinc; Zinc-finger.
FT   CHAIN           1..961
FT                   /note="FYVE, RhoGEF and PH domain-containing protein 1"
FT                   /id="PRO_0000080940"
FT   DOMAIN          373..561
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          590..689
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          821..921
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   ZN_FING         730..790
FT                   /note="FYVE-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   REGION          1..353
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          702..726
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          925..961
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           171..187
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        141..190
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        229..254
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        283..300
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        336..352
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         736
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         739
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         753
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         756
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         761
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         764
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         782
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         785
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   MOD_RES         48
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         205
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         711
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         715
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VARIANT         205
FT                   /note="S -> I (in AAS)"
FT                   /evidence="ECO:0000269|PubMed:14560308"
FT                   /id="VAR_019268"
FT   VARIANT         312
FT                   /note="P -> L (in dbSNP:rs28935498)"
FT                   /evidence="ECO:0000269|PubMed:11940089"
FT                   /id="VAR_019269"
FT   VARIANT         380
FT                   /note="E -> A (in AAS)"
FT                   /evidence="ECO:0000269|PubMed:14560308"
FT                   /id="VAR_019270"
FT   VARIANT         443
FT                   /note="R -> H (in AAS; dbSNP:rs137853266)"
FT                   /evidence="ECO:0000269|PubMed:14560308"
FT                   /id="VAR_019271"
FT   VARIANT         522
FT                   /note="R -> H (in AAS; dbSNP:rs137853264)"
FT                   /evidence="ECO:0000269|PubMed:11093277"
FT                   /id="VAR_015236"
FT   VARIANT         610
FT                   /note="R -> Q (in AAS; dbSNP:rs28935497)"
FT                   /evidence="ECO:0000269|PubMed:10930571"
FT                   /id="VAR_015237"
FT   CONFLICT        10..23
FT                   /note="AGPSEPEHPATNPP -> RRAFGARTPGHEPA (in Ref. 1)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        195
FT                   /note="A -> G (in Ref. 1; AAA57004)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   961 AA;  106561 MW;  30963F7B9931E45C CRC64;
     MHGHRAPGGA GPSEPEHPAT NPPGAAPPAC ADSDPGASEP GLLARRGSGS ALGGPLDPQF
     VGPSDTSLGA APGHRVLPCG PSPQHHRALR FSYHLEGSQP RPGLHQGNRI LVKSLSLDPG
     QSLEPHPEGP QRLRSDPGPP TETPSQRPSP LKRAPGPKPQ VPPKPSYLQM PRMPPPLEPI
     PPPPSRPLPA DPRVAKGLAP RAEASPSSAA VSSLIEKFER EPVIVASDRP VPGPSPGPPE
     PVMLPQPTSQ PPVPQLPEGE ASRCLFLLAP GPRDGEKVPN RDSGIDSISS PSNSEETCFV
     SDDGPPSHSL CPGPPALASV PVALADPHRP GSQEVDSDLE EEDDEEEEEE KDREIPVPLM
     ERQESVELTV QQKVFHIANE LLQTEKAYVS RLHLLDQVFC ARLLEEARNR SSFPADVVHG
     IFSNICSIYC FHQQFLLPEL EKRMEEWDRY PRIGDILQKL APFLKMYGEY VKNFDRAVEL
     VNTWTERSTQ FKVIIHEVQK EEACGNLTLQ HHMLEPVQRI PRYELLLKDY LLKLPHGSPD
     SKDAQKSLEL IATAAEHSNA AIRKMERMHK LLKVYELLGG EEDIVSPTKE LIKEGHILKL
     SAKNGTTQDR YLILFNDRLL YCVPRLRLLG QKFSVRARID VDGMELKESS NLNLPRTFLV
     SGKQRSLELQ ARTEEEKKDW VQAINSTLLK HEQTLETFKL LNSTNREDED TPPNSPNVDL
     GKRAPTPIRE KEVTMCMRCQ EPFNSITKRR HHCKACGHVV CGKCSEFRAR LVYDNNRSNR
     VCTDCYVALH GVPGSSPACS QHTPQRRRSI LEKQASVAAE NSVICSFLHY MEKGGKGWHK
     AWFVVPENEP LVLYIYGAPQ DVKAQRSLPL IGFEVGPPEA GERPDRRHVF KITQSHLSWY
     FSPETEELQR RWMAVLGRAG RGDTFCPGPT LSEDREMEEA PVAALGATAE PPESPQTRDK
     T
//
